For people living with a rare disease, the journey can begin long before treatment—with uncertainty, delayed diagnosis, limited awareness and difficult pathways to care.
At Healing Wings Foundation, we believe that every patient deserves to be seen, heard and supported.
Our rare disease advocacy work brings together patients, healthcare professionals, researchers, institutions, government stakeholders and partners to address the challenges that can stand between a patient and appropriate care.
Because being rare should never mean being overlooked.
A rare disease may affect a small number of people individually, but together, rare diseases represent a significant healthcare challenge. Patients and families can face multiple barriers:
Advocacy helps bring these challenges into the conversation—and works towards practical solutions.
We focus on moving beyond awareness to meaningful action.
Understanding the experiences, challenges and unmet needs of people living with rare diseases and their families.
Working to improve understanding of rare diseases among healthcare and community stakeholders.
Supporting initiatives that can improve pathways to diagnosis, treatment and appropriate patient-support programmes.
Engaging with relevant government and institutional stakeholders on issues affecting rare disease patients.
Bringing together healthcare institutions, researchers, patient communities, government stakeholders and other partners to work towards common solutions.
Encouraging research and innovative approaches that can contribute to earlier identification, improved care and better patient access.
Our advocacy is connected to initiatives on the ground.
HWF has submitted a proposal to the Government of Kerala for mass screening programmes for rare diseases in government district hospitals and medical college hospitals, which is under active consideration.
HWF has submitted a proposal to the Government of Tamil Nadu to explore connecting identified rare disease patients with Patient Access Programmes run by pharmaceutical organisations through a public-private partnership model.
HWF has recommended repurposed orphan drugs to the Indian Council of Medical Research (ICMR) for clinical trials in India, with the objective of exploring ways to reduce the cost of orphan drugs.
HWF has conducted a Patient Advocacy Programme for Epidermolysis Bullosa patients and has also engaged in discussions around EB research and potential collaborations.
No single organisation can transform the rare disease landscape alone.
We believe progress happens when different voices come together.
Bringing lived experiences to the centre of the conversation.
Connecting clinical expertise with patient needs.
Encouraging research and innovation.
Supporting dialogue around policy and healthcare priorities.
Exploring responsible pathways to improve access.
Strengthening awareness, support and community engagement.
"A healthcare ecosystem where rare disease patients are identified earlier, heard more clearly and connected to appropriate care."
We envision a future where:
At Healing Wings Foundation, advocacy means listening, connecting, collaborating and acting—so that the needs of people living with rare diseases remain visible in healthcare conversations and decisions.
Be Part of the Change